Nutrition Intervention to Address Anemia Among Adolescent Girls in Liberia

NCT05073562 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-11-22

No results posted yet for this study

Summary

The purpose of this study is to evaluate the feasibility and effectiveness of weekly iron and folic acid (IFA) supplementation and one-time deworming treatment at the community level in improving hemoglobin levels among adolescent girls in Liberia, West Africa, and to assess the feasibility and effectiveness of a targeted nutrition education program in improving nutrition knowledge, attitudes, and practices in the same population.

Conditions

  • Nutritional Anemia
  • Nutritional Deficiency
  • Iron Deficiency Anemia Treatment
  • Folic Acid Deficiency Anemia, Dietary
  • Adolescent Development
  • Knowledge, Attitudes, Practice
  • Food Habits

Interventions

DIETARY_SUPPLEMENT

Iron and folic acid (IFA) supplementation

Weekly IFA supplementation for duration of the study.

BEHAVIORAL

Targeted nutrition education

Structured nutrition education package delivered at household level by trained Community Health Assistants (CHAs)

DRUG

Mebendazole Pill

One-time deworming treatment with mebendazole.

OTHER

Standard nutrition services

Basic nutrition services currently provided at the health facility and at community level in Liberia

Sponsors & Collaborators

  • UNICEF

    collaborator OTHER
  • Ministry of Health, Liberia

    collaborator OTHER
  • Liberia Institute of Statistics and Geo-Information Services

    collaborator UNKNOWN
  • Boston Children's Hospital

    lead OTHER

Principal Investigators

  • Julia Rubin-Smith, MD, MSPH · Boston Children's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
19 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-31
Primary Completion
2021-12-31
Completion
2021-12-31

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05073562 on ClinicalTrials.gov